Ataxia telangiectasia medical therapy: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Ataxia telangiectasia}} | {{Ataxia telangiectasia}} | ||
{{CMG}} | {{CMG}} | ||
== Medical Therapy == | == Medical Therapy == | ||
Revision as of 15:20, 29 November 2012
|
Ataxia telangiectasia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ataxia telangiectasia medical therapy On the Web |
|
American Roentgen Ray Society Images of Ataxia telangiectasia medical therapy |
|
Risk calculators and risk factors for Ataxia telangiectasia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Medical Therapy
Treatment is symptomatic and supportive. Physical and occupational therapy may help maintain flexibility. Speech therapy may also be needed. Gamma-globulin injections may be given to help supplement a weakened immune system. High-dose vitamin regimens may also be used. Antibiotics are used to treat infections. Some physicians recommend low doses of chemotherapy to reduce the risk of cancer but this is controversial. It is also recommended that heterozygote family members are regularly monitored for cancers. Recently desferroxamine was shown to increase the stability of AT cells and may prove to be an effective treatment for the disorder.
Genetic Counseling
All individuals with AT should undergo genetic counseling along with their families. This is especially important due to the increased risk of cancers that heterozygotes have. There is also an associated risk to any other children born to the parents of the affected child.